Golgi Architecture and Its Maintenance {#Sec1}
======================================

The Golgi apparatus is a central intracellular membrane-bound organelle often located adjacent to the nucleus in mammalian cells. Electron microscope (EM) images revealed its unique feature as stacks of five to seven flattened cisternae overlaying one another, with multiple stacks often lined up and interconnected by tubular structures to form a ribbon (Shorter and Warren [@CR258]; Rabouille and Kondylis [@CR222]; Wei and Seemann [@CR310]). The Golgi stacks are polarized; they receive proteins and lipids from the endoplasmic reticulum (ER) by the *cis* cisternae and export them from the *trans* cisternae and the *trans*-Golgi network (TGN) to other intracellular membranes such as the endosomes, lysosomes, plasma membrane, and outside of the cell (Tang and Wang [@CR279]; Wang and Seemann [@CR302]). While traversing the Golgi stack, cargo molecules are modified and processed. The sub-compartments of the Golgi stacks house a set of glycosidases and glycosyltransferases responsible for the synthesis of glycoproteins and glycolipids. In the TGN, many secretory proteins are proteolytically cleaved by lumenal proteinases (Huang and Wang [@CR113]; Zhang and Wang [@CR334]; Huttner et al. [@CR115]).

Many efforts have been made to understand the mechanism of Golgi structure formation. The formation of the Golgi ribbon depends on Golgi matrix proteins and an intact microtubule organization. Cytosolic dynein moves Golgi membranes along centrosome-derived microtubules toward the (--) end of the microtubules (Matteis et al. [@CR176]; Rabouille and Kondylis [@CR222]; Wei and Seemann [@CR310]). Subsequently, Golgi-oriented microtubules maintain Golgi stacks in the proximity and facilitate tubular connections between them (Zhu and Kaverina [@CR344]). While dynein and microtubules are required for the concentration of Golgi stacks in the pericentrosomal region and Golgi ribbon formation, they are not essential for the generation and maintenance of the stacked structure, as depolymerization of microtubules disrupts the Golgi ribbon but not the stacks (Thyberg and Moskalewski [@CR287]). From the 1960s, morphological studies have shown connections in the space between cisternae that might be involved in the adhesion of cisternae into stacks (Franke et al. [@CR72]; Mollenhauer [@CR184]; Cluett and Brown [@CR45]), which were later identified as Golgi matrix proteins. These include Golgi stacking proteins and membrane tethers, as discussed below.

Golgi Matrix Proteins and Golgi Structure Formation {#Sec2}
---------------------------------------------------

In 1994, the concept of "Golgi matrix" proteins was first introduced (Slusarewicz et al. [@CR264]). Since then, several Golgi matrix proteins have been identified to be responsible for maintaining the unique architecture and function of the Golgi apparatus. Major components of the Golgi matrix are summarized in Table [19.1](#Tab1){ref-type="table"}. Key proteins involved in Golgi structure formation are discussed below.Table 19.1Major components of the Golgi matrixNamesGolgi localizationMembrane anchorAssociated GTPasesInteractionsFunctions*GRASPs*GRASP55/GORASP2*medial/trans*N-myr (Shorter et al. [@CR259])Rab2 (Barr [@CR17]; Short et al. [@CR255])-- Golgin-45 (Short et al. [@CR255]; Zhao et al. [@CR341])-- p24 (Barr et al. [@CR20])-- TGF-α (Kuo et al. [@CR137])-- LC3, LAMP2 (Zhang et al. [@CR340])-- Sec16 (Piao et al. [@CR503])-- CFTR (Gee et al. [@CR81])-- JAM-B, JAM-C (Cartier-Michaud et al. [@CR36])-- KCTD5 (Dementieva et al. [@CR501])• Golgi stacking (Shorter et al. [@CR259]; Xiang and Wang [@CR319]; Bekier et al. [@CR22])• Golgi ribbon formation (Feinstein and Linstedt [@CR69])• Cell cycle control (Duran et al. [@CR63])• Transport of specific cargo (Kuo et al. [@CR137]; D'Angelo et al. [@CR50])• p24 cargo receptor retention (Barr et al. [@CR20])• Autophagy (Zhang et al. [@CR340]; Zhang and Wang [@CR335], [@CR336])• Unconventional secretion (Dupont et al. [@CR62]; Rabouille and Linstedt [@CR223]; Vinke et al. [@CR297]; Gee et al. [@CR81]; Piao et al. [@CR503])• Spermatogenesis (Cartier-Michaud et al. [@CR36])GRASP65/GORASP1*cis*N-myr (Barr et al. [@CR18])-- GM130 (Barr et al. [@CR19])-- Mena (Tang et al. [@CR285])-- DjA1 (Li et al. [@CR502])-- p24 (Barr et al. [@CR20])-- CD8a, Frizzled 4 (D'Angelo et al. [@CR50])-- Bcl-X~L~ (Cheng et al. [@CR39])• Stacking (Barr et al. [@CR18]; Xiang and Wang [@CR319]; Bekier et al. [@CR22]; Shin et al. [@CR253])• Golgi ribbon formation (Puthenveedu et al. [@CR220]; Tang et al. [@CR285])• Cell cycle progression (Preisinger et al. [@CR218]; Sutterlin et al. [@CR276]; Yoshimura et al. [@CR329]; Duran et al. [@CR63]; Tang et al. [@CR282])• Mitotic spindle formation (Sutterlin et al. [@CR276])• Transport of specific cargo (D'Angelo et al. [@CR50])• p24 cargo receptor retention (Barr et al. [@CR20])• Unconventional secretion (Gee et al. [@CR81])• Apoptosis (Lane et al. [@CR138])*Golgins*GM130/GOLGA2*cis*PRab1 (Weide et al. [@CR312])-- p115 (Nakamura et al. [@CR192])-- GRASP65 (Hu et al. [@CR112])-- Syntaxin 5 (Diao et al. [@CR57])-- AKAP450 (Rivero et al. [@CR236])-- ZFPL1 (Chiu et al. [@CR44])-- Tuba (Kodani et al. [@CR132])• Golgi ribbon formation (Puthenveedu et al. [@CR220])• COPII vesicle tethering (Moyer et al. [@CR186]; Alvarez et al. [@CR6])• Non-centrosomal microtubule organization (Rivero et al. [@CR236])• Centrosome regulation (Kodani and Sutterlin [@CR131]; Kodani et al. [@CR132])• Spindle formation (Kodani and Sutterlin [@CR131])• Cell migration (Preisinger et al. [@CR217])• Apoptosis (Walker et al. [@CR299])• Purkinje neuron development (Liu et al. [@CR153])p115*cis*PRab1 (Allan et al. [@CR4])-- GM130 (Nakamura et al. [@CR192])-- Giantin (Sonnichsen et al. [@CR269])-- syntaxin 5, GOS-28 (Shorter et al. [@CR260])• Post-mitotic Golgi reassembly (Shorter and Warren [@CR257]; Brandon et al. [@CR27]; Dirac-Svejstrup et al. [@CR59])• SNARE assembly (Wang et al. [@CR307]; Shorter et al. [@CR260])• Membrane tethering (Shorter and Warren [@CR257]; Nakamura et al. [@CR192]; Alvarez et al. [@CR6]; Seemann et al. [@CR248]; Shorter et al. [@CR260]; Allan et al. [@CR4])• Apoptosis (Chiu et al. [@CR43])• Nuclear import (Mukherjee and Shields [@CR187])Giantin/GOLGB1*cis/medial*TMDRab1/6 (Rosing et al. [@CR238])-- p115 (Sonnichsen et al. [@CR269])-- GM130 (Sonnichsen et al. [@CR269])-- GCP60/ACBD3 (Sohda et al. [@CR265])• Golgi stack organization (Rosing et al. [@CR238]; Koreishi et al. [@CR135])• Ribbon organization (Koreishi et al. [@CR135])• Membrane tethering (Sonnichsen et al. [@CR269]; Linstedt et al. [@CR149]; Lowe et al. [@CR156]; Misumi et al. [@CR182]; Derby and Gleeson [@CR54]; Alvarez et al. [@CR6]; Munro [@CR189])• ER-to-Golgi trafficking (Sohda et al. [@CR265])• Apoptosis (Lowe et al. [@CR156])• Cilia formation (Bergen et al. [@CR24])Golgin-45/BLZF1*medial/trans*PRab2 (Short et al. [@CR255])-- GRASP55 (Short et al. [@CR255], Zhao et al. [@CR341])• Golgi stacking (Short et al. [@CR255], Zhao et al. [@CR341])• Membrane tethering (Short et al. [@CR255])Golgin-67/GOLGA8BTMD^a^• Uncharacterized (Jakymiw et al. [@CR116], Eystathioy et al. [@CR66])Golgin-84/GOLGA5*cis*TMDRab1(Satoh et al. [@CR243])-- CASP (Osterrieder et al. [@CR206])-- COG complex (Sohda et al. [@CR266])• Golgi stacking and reassembly (Satoh et al. [@CR243])• Golgi ribbon formation (Diao et al. [@CR56])• ER-Golgi tethering and protein transport (Osterrieder et al. [@CR206])• Membrane tethering (Malsam et al. [@CR169])• Intra-Golgi retrograde transport (Sohda et al. [@CR266])• Proinsulin conversion (Liu et al. [@CR152])• Tau phosphorylation in Alzheimer's disease (Jiang et al. [@CR118])• Bacterial infection (Rejman Lipinski et al. [@CR231])Golgin-97/GOLGA1*trans*GRIPARL1/3 (Lu and Hong [@CR157])Rab6/19/30 (Sinka et al. [@CR262])-- TBC1D23 (Shin et al. [@CR252], [@CR253])• TGN-to-PM trafficking of E-cadherin (Lock et al. [@CR154])• Endosome-to-TGN trafficking (Lu and Hong [@CR157]; Lu et al. [@CR158])• Retrograde transport from recycling endosomes to the TGN (Jing et al. [@CR119])• Poxvirus morphogenesis (Alzhanova and Hruby [@CR8])Golgin-160/GOLGA3/GCP170*cis*P-- GCP60/ACBD3 (Sbodio et al. [@CR245]; Sbodio and Machamer [@CR244])-- GCP16 (Ohta et al. [@CR204])-- β1AR (Gilbert et al. [@CR85])-- ROMK, PIST (Bundis et al. [@CR30])• Post-Golgi trafficking (Bundis et al. [@CR30]; Gilbert et al. [@CR85])• Apoptosis (Mancini et al. [@CR170], Maag et al. [@CR164], Sbodio et al. [@CR245])Golgin-245/GOLGA4/p230*trans*GRIPARL1/3 (Wu et al. [@CR318]; Sinka et al. [@CR262])Rab2/6/19/30 (Sinka et al. [@CR262])-- TBC1D23 (Shin et al. [@CR252], [@CR253])• TGN-to-PM traffic (Lu and Hong [@CR157])• Phagophore formation (Sohda et al. [@CR267])GCP16Acylation-- Golgin-160/GOLGA1/GCP170 (Ohta et al. [@CR204])• Golgi-to-PM trafficking (Ohta et al. [@CR204])GCC88*trans*GRIPARL1/3 (Sinka et al. [@CR262]), Rab6/19/30 (Sinka et al. [@CR262])• TGN organization and endosome-to-TGN trafficking (Luke et al. [@CR160]; Lieu et al. [@CR145])• Golgi ribbon formation (Gosavi et al. [@CR90])• Actin organization (Makhoul et al. [@CR168])GCC185*trans*GRIPARL1/3 (Sinka et al. [@CR262])ARL4A (Lin et al. [@CR147])Rab1/2/6/9/30 (Burguete et al. [@CR31], Sinka et al. [@CR262], Hayes et al. [@CR101])-- Syntaxin 16 (Ganley et al. [@CR79])-- CLASP (Efimov et al. [@CR64])• Golgi ribbon formation (Derby et al. [@CR55])• Golgi integrity (Lin et al. [@CR147])• Membrane tethering (Derby et al. [@CR55]; Reddy et al. [@CR230]; Ganley et al. [@CR79])• MPR recycling (Reddy et al. [@CR230])• Attachment of non-centrosomal microtubules (Efimov et al. [@CR64])ACBD3/GCP60P-- Golgin-45 (Yue et al. [@CR330])-- giantin (Sohda et al. [@CR265])-- Golgin-160 (Sbodio and Machamer [@CR244]; Sbodio et al. [@CR245])-- PI4KIIIβ (Greninger et al. [@CR93])-- TBC1D22 (Greninger et al. [@CR94])-- Aichi virus (Sasaki et al. [@CR242])-- Poliovirus 3A protein (Greninger et al. [@CR94])-- Numb (Zhou et al. [@CR342])• Golgi integrity and ER-to-Golgi trafficking (Sohda et al. [@CR265])• Nuclear translocation of caspase-generated Golgin-160 fragments (residues 140-311) (Sbodio and Machamer [@CR244], Sbodio et al. [@CR245])• Asymmetric cell division (Zhou et al. [@CR342])• Aichi virus and poliovirus replication (Greninger et al. [@CR93])Bicaudal-D/BICD2PRab6-- Dynactin, p50-dynamitin (Hoogenraad et al. [@CR108])• Recruitment of the dynein-dynactin complex (Hoogenraad et al. [@CR108])• COPI-independent Golgi-to-ER transport (Matanis et al. [@CR175])• Endosome-to-Golgi transport (Wanschers et al. [@CR308])• Autosomal-dominant spinal muscular atrophy (Neveling et al. [@CR196], Martinez-Carrera and Wirth [@CR173])CASP/Coy1*cis*TMD-- Golgin-84 (Osterrieder et al. [@CR206])-- Cog3, Sed5, Sly1, Gos1, Sft1/GS15 (Anderson et al. [@CR9])• ER-Golgi tethering and protein transport (Osterrieder et al. [@CR206])• Retrograde-directed COPI vesicles (Anderson et al. [@CR9])CG-NAP-- PKN, RIIα, PP2A, protein phosphatase 1 (Takahashi et al. [@CR277])-- Dynein (Kim et al. [@CR127])-- Cyclin E (Nishimura et al. [@CR201])-- Kendrin, GCP2, γ-tubulin (Takahashi et al. [@CR278])-- CK1δ (Sillibourne et al. [@CR261])• Scaffold protein for kinases/phosphatases (Takahashi et al. [@CR277])• Centrosome amplification (Nishimura et al. [@CR201])• Microtubule nucleation (Takahashi et al. [@CR278])COH1/VPS13B*cis*P• Golgi ribbon formation (Seifert et al. [@CR249])GCP364C-terminal hydrophobic domain• Golgi ribbon formation and perinuclear localization (Toki et al. [@CR288])GMAP-210/Trip11/Trip230*cis*GRAB (Gillingham et al. [@CR87])ARF1 (Gillingham et al. [@CR87])-- ITF20, γ-tubulin (Rios et al. [@CR233])-- Thyroid receptor (Chen et al. [@CR38])• Golgi ribbon formation (Rios et al. [@CR233])• Membrane tethering (Drin et al. [@CR61])• ER-to-Golgi trafficking (Gillingham et al. [@CR87])• γ-tubulin recruitment (Rios et al. [@CR233])• Sorting to primary cilia (Follit et al. [@CR70])• Interacts with thyroid hormone receptor beta (Chen et al. [@CR38])IIGP165P• Anti-apoptosis (Ran et al. [@CR227])Imh1/SYS3*trans*GRIPARL1/Arl1p (Panic et al. [@CR207])-- Env7 (Rao et al. [@CR228])• Endosome-to-Golgi trafficking (Tsukada et al. [@CR290])Lava lamp/Lva-- Dynein heavy chain, Lrrk (Lin et al. [@CR148])• Dynein-based Golgi movements (Papoulas et al. [@CR209])NECC1/2TMD^a^• Uncharacterized (Cruz-Garcia et al. [@CR48])SCOCOP• Uncharacterized (Van Valkenburgh et al. [@CR295])SCYL1BP1/GORABPRab6 (Hennies et al. [@CR103])-- Scyl1• Gerodermia osteodysplastica (Hennies et al. [@CR103]; Al-Dosari and Alkuraya [@CR3])• Suppresses Schwann cell (SC) differentiation and neurite outgrowth by enhancing the Rhoa Pathway (Zhang et al. [@CR338])• Type 2 diabetes (Peng et al. [@CR213])• Suppression of hepatocellular carcinoma development (Hu et al. [@CR111])TMP/ARA160PRab6 (Fridmann-Sirkis et al. [@CR73])-- hSNF2a/b (Mori and Kato [@CR185])-- Fer, AR (Hsiao and Chang [@CR110])-- Stat3 (Perry et al. [@CR214])• Golgi integrity (Fridmann-Sirkis et al. [@CR73])• Early/recycling endosomes-to-TGN trafficking, Golgi enzyme retention (Yamane et al. [@CR326], Ramirez and Lowe [@CR226])*Other Golgi structural proteins*p24/TMED2*cis*TMD-- GRASP55 (Barr et al. [@CR20])-- GRASP65 (Barr et al. [@CR20])• Post-Golgi trafficking (Luo et al. [@CR163])• GPI-anchored proteins export from the ER (Bonnon et al. [@CR26])p28*cis*• Golgi ribbon formation (Koegler et al. [@CR133])p37*trans*P-- p97 (Uchiyama et al. [@CR292])• Membrane fusion (Uchiyama et al. [@CR292])p47*trans*P-- VCIP135 (Zhang and Wang [@CR332])-- p97 (Kondo et al. [@CR134])• Post-mitotic Golgi reassembly (Zhang and Wang [@CR332])p97/VCP*trans*P-- VCIP135 (Zhang and Wang [@CR332])-- p47 (Kondo et al. [@CR134])-- p37 (Uchiyama et al. [@CR292])-- YOD1, UBXD1 and PLAA (Papadopoulos et al. [@CR208])• Post-mitotic Golgi reassembly (Zhang and Wang [@CR332])• Membrane reassembly (Kondo et al. [@CR134]; Ramadan et al. [@CR225]; Hetzer et al. [@CR104])• Cell cycle progression (Cao et al. [@CR34]; Fu et al. [@CR74]; Parisi et al. [@CR210])• Protein aggregation (Ghosh et al. [@CR84]; Ristic et al. [@CR235]; Yi and Yuan [@CR327]; Kobayashi et al. [@CR130]; Song et al. [@CR268]; Nishikori et al. [@CR200])• Autophagy (Papadopoulos et al. [@CR208])• DNA repair (Van Den Boom et al. [@CR293]; Fujita et al. [@CR78]; Davis et al. [@CR51]; Meerang et al. [@CR178]; Partridge et al. [@CR212])• ER-stress-induced gene transcription (Marza et al. [@CR174])• Antiviral signaling (Hauler et al. [@CR100], Hao et al. [@CR98])*ACBD* Acyl-CoA-binding domain-containing protein, *AKAP* A-kinase anchor protein, *AR* [adrenergic receptor, *ARL* ADP-ribosylation factor-like protein, *BICD2* protein bicaudal D homolog 2, *CFTR* cystic fibrosis transmembrane conductance regulator,](https://en.wikipedia.org/wiki/Beta-1_adrenergic_receptor) *CG-NAP* centrosome- and Golgi-localized PKN-associated protein, *CK* casein kinase, *COG complex* conserved oligomeric Golgi complex, *COH* Cohen syndrome protein, *DjA1* DnaJ homolog subfamily A member 1, *GCP* Golgi complex-associated protein, *GMAP* Golgi-associated microtubule-binding protein, *GORAB* RAB6-interacting golgin, *GPI* glycosylphosphatidylinositol, *GRAB* GRIP-related ARF-binding domain, *GRIP* Arl-binding domain, *KCTD5* potassium channel tetramerization domain-containing protein 5, *Lrrk* leucine-rich repeat serine/threonine-protein kinase, *Mena* mammalian enabled homologue, *MPR* mannose 6-phosphate receptor, *NECC* neuroendocrine long coiled-coil protein, *N-Myr* amino-terminal myristoylation, *P* peripheral membrane protein, *PIST* PDZ protein interacting specifically with TC10, *PM* plasma membrane, *ROMK* renal outer medullary potassium, *SCOCO* short coiled-coil protein, *SNARE* soluble NSF attachment protein receptor, *TBC1D23* TBC1 domain family member 23, *TGN trans*-Golgi network, *TGF* transforming growth factor, *TMD* transmembrane domain, *TMED* transmembrane emp24 domain-containing protein, *VCIP* valosin-containing protein p97/p47 complex-interacting protein, *VCP* valosin-containing protein, *VPS* vacuolar protein sorting-associated protein, *ZFPL1* zinc finger protein-like 1This table is updated from Xiang and Wang ([@CR320])^a^Predicted

### Golgi *R*e*A*ssembly *S*tacking Proteins (GRASPs) {#Sec3}

Among all Golgi matrix proteins, the Golgi ReAssembly Stacking Proteins GRASP65 and GRASP55 (GRASPs, also called GORASP1 and GORASP2, respectively) are best characterized for their roles in Golgi structure formation, including stacking (Wang et al. [@CR303], Shorter et al. [@CR259], Xiang and Wang [@CR319], Bekier et al. [@CR22], Shin et al. [@CR253], Barr et al. [@CR18]), ribbon-linking (Puthenveedu et al. [@CR220]; Tang et al. [@CR285]; Feinstein and Linstedt [@CR69]), cargo transportation (Kuo et al. [@CR137]; D'Angelo et al. [@CR50]; Barr et al. [@CR20]), unconventional secretion (Dupont et al. [@CR62]; Rabouille and Linstedt [@CR223]; Vinke et al. [@CR297]; Gee et al. [@CR81]; Piao et al. [@CR503]), cell cycle regulation (Preisinger et al. [@CR218]; Sutterlin et al. [@CR276]; Yoshimura et al. [@CR329]; Duran et al. [@CR63]; Tang et al. [@CR282]), apoptosis (Lane et al. [@CR138]), and autophagy (Zhang et al. [@CR340]; Zhang and Wang [@CR335], [@CR336]), although the mechanisms are less well understood.

Both GRASPs share a similar structure: a conserved N-terminal GRASP domain consisting of two PDZ domains (PDZ1 and PDZ2) and an intrinsically disordered C-terminal Serine/Proline-Rich (SPR) domain with multiple phosphorylation sites (Zhang and Wang [@CR333]) (Fig. [19.1](#Fig1){ref-type="fig"}). Both GRASP65 and GRASP55 are peripheral membrane proteins that are attached to the Golgi membranes via an N-terminal myristic acid modification and the interaction with their membrane-bound partner proteins (GM130 and Golgin-45, respectively) and therefore are concentrated at the interface between the cisternae where stacking occurs (Short et al. [@CR255]; Barr et al. [@CR19]). GRASP65 is concentrated on the *cis-*Golgi cisternae, whereas GRASP55 localizes to the *medial/trans*-Golgi cisternae (Barr et al. [@CR18]; Shorter et al. [@CR259]). Both play complementary roles in Golgi stack formation (Xiang and Wang [@CR319]).Fig. 19.1Structure, modification, and binding sites on GRASP65 (**a**) and GRASP55 (**b**). Rat GRASP65 and GRASP55 sequences are used for illustration. Both GRASPs share a similar structure: a conserved N-terminal GRASP domain consisting of two PDZ domains (PDZ1 and PDZ2) and a C-terminal Serine/Proline-Rich (SPR) domain with multiple phosphorylation sites (indicated by asterisks) that are involved in GRASP modulation during the cell cycle. Both GRASP65 and GRASP55 are peripheral membrane proteins attached to the Golgi membranes via N-terminal myristoylation and the interaction with their membrane-bound partner proteins (GM130 and Golgin-45, respectively). GRASP65-binding proteins Mena and DjA1 have been identified to enhance Golgi ribbon linking and stacking, respectively. GRASP55 is regulated by O-GlcNAcylation depending on the glucose level and interacts with LC3 and LAMP2 to facilitate glucose starvation-induced autophagy

Mechanistically, GRASP proteins form homodimers via the N-terminal PDZ domains, and dimers from adjacent Golgi cisternae further oligomerize in *trans* and function as the "glue" that tethers the cisternae into a stack (Wang et al. [@CR303], [@CR305]). An in vitro study using modified GRASP domain peptides indicated that insertion of the myristic acid moiety is required for the oriented association to Golgi membranes, which ensures the protein-protein interaction in *trans*. Furthermore, the conformational change caused by myristoylation affects the tendency of GRASP domain for self-interaction (Heinrich et al. [@CR102]). Depletion of either GRASP65 or GRASP55 reduces the number of cisternae per Golgi stack, whereas depletion of both GRASPs leads to disassembly of the entire Golgi stack (Sutterlin et al. [@CR276], Xiang and Wang [@CR319], Bekier et al. [@CR22]). The GRASPs are tightly modulated by a phosphorylation and dephosphorylation cycle during cell division, resulting in mitotic disassembly and post-mitotic reassembly of the Golgi (Feinstein and Linstedt [@CR69]; Cervigni et al. [@CR37]; Lin et al. [@CR146]; Wang et al. [@CR303]; Preisinger et al. [@CR218]; Tang et al. [@CR284]; Xiang and Wang [@CR319]; Tang et al. [@CR280]; Truschel et al. [@CR289]).

Recent studies have identified novel GRASP-binding proteins involved in Golgi biogenesis and morphology modulation. Recent research of the crystal structure of GRASP55 bound to the Golgin-45 C-terminal peptide revealed that Golgin-45 promotes the oligomerization of GRASP55 by forming a new interaction between two neighboring PDZ2 molecules to play an important role in Golgi stacking (Zhao et al. [@CR341]). Meanwhile, using an optimized in vitro system, mammalian enabled homologue (Mena) and DnaJ homolog subfamily A member 1 (DjA1) were identified as GRASP65 binding partners with potential functions on Golgi structure maintenance (Tang et al. [@CR285]; Li et al. [@CR502]). Mena is an actin elongation factor recruited to the Golgi membranes by GRASP65 to facilitate actin polymerization and GRASP65 oligomerization and thus functions with actin as bridging proteins of GRASP65 in Golgi ribbon linking. DjA1 is a co-chaperone of Heat shock cognate 71 kDa protein (Hsc70), but the activity of DjA1 in Golgi structure formation is independent of its co-chaperone activity or Hsc70, rather, through DjA1-GRASP65 interaction to promote GRASP65 oligomerization. Thus, DjA1 facilitates Golgi structure formation through an unconventional Hsc70-independent pathway. These studies further confirmed GRASP65 as a multifaceted protein in Golgi structure formation and indicated that an array of GRASP binding proteins could play important roles in Golgi morphology maintenance (Fig. [19.1](#Fig1){ref-type="fig"}). In addition, GRASP55 was reported to be involved in glucose starvation-induced autophagy (Zhang et al. [@CR340]), where it interacts with LC3 on autophagosomes and LAMP2 on lysosomes to facilitate autophagosome maturation, which will be discussed in later sections.

### Golgins {#Sec4}

Golgins are a family of Golgi-associated coiled-coil [proteins](https://en.wiktionary.org/wiki/protein) that are necessary for vesicle tethering at the Golgi and maintenance of Golgi integrity (Muschalik and Munro [@CR190]; Witkos and Lowe [@CR316]; Gillingham and Munro [@CR86]). Most golgins are peripheral membrane proteins anchored on Golgi membranes via their C-terminus and are associated with small GTPases of Rab, Arf, and Arl families (Table [19.1](#Tab1){ref-type="table"}) (Munro [@CR189]; Sinka et al. [@CR262]). These interactions mediate both membrane attachment and selective localization of a specific golgin to a specific sub-compartment of the Golgi (Witkos and Lowe [@CR316]). Golgins lack significant sequence homology between the family members and localize to different regions of the Golgi to play distinct roles in tethering events, membrane traffic, and Golgi organization. The coiled-coil regions provide the golgins with an extended structure required for the tethering function, while the interactions with Rab GTPases control these molecules in their open (extended) or closed (folded) confirmation (Cheung et al. [@CR40]). In addition, golgins often contain specific sequence and structural features at the N- and C-terminal ends, which allow them to recognize vesicles and Golgi cisternal membranes based on the curvature and lipid composition of the membranes (Drin et al. [@CR61]; Drin et al. [@CR60]; Magdeleine et al. [@CR167]). Detailed information about golgins and their functions are summarized in Table [19.1](#Tab1){ref-type="table"}.

GM130 was the first identified Golgi matrix protein and is predominantly found in the central region of the *cis*-Golgi (Nakamura et al. [@CR191]), where it forms a stable complex with GRASP65 (Barr et al. [@CR19]). Depletion of GM130 results in the disruption of the Golgi ribbon and causes protein glycosylation defects (Puthenveedu et al. [@CR220]). There are two possible ways GM130 contributes to Golgi ribbon formation. First, GM130 targets GRASP65 to the rim of the cisternae where GRASP65 promotes lateral linking of cisternae via oligomerization (Puthenveedu et al. [@CR220]). Mena and actin cytoskeleton may facilitate GRASP65 in this action (Tang et al. [@CR285]). Second, GM130 recruits A-kinase anchoring protein 450 (AKAP450) onto the *cis*-Golgi and allows Golgi-associated nucleation of microtubules, which arranges Golgi stacks in close proximity to form a ribbon (Rivero et al. [@CR236]). Similarly, other golgins may also work with the microtubule cytoskeleton in a similar way to facilitate Golgi structure organization. For example, GMAP-210, another *cis*-Golgi-localized golgin, recruits the γ-tubulin-containing complexes to the Golgi membranes and promotes the formation of tubulin oligomers on Golgi membranes. Depletion of GMAP-210 results in extensive Golgi fragmentation, suggesting a role in Golgi ribbon formation (Rios et al. [@CR233]).

In addition to GRASP65, GM130 also interacts with p115 and giantin to form the GM130-p115-giantin tethering complex (Sonnichsen et al. [@CR269]). The Rab1 effector p115, when recruited to coat protein complex (COP) II vesicles during the budding from the ER, interacts with the soluble ATPases *N*-ethylmaleimide-sensitive factor (NSF) attachment protein receptors (SNAREs), a specialized set of COPII v-SNAREs, to form a *cis-*SNARE complex that promotes vesicle targeting to the Golgi apparatus (Allan et al. [@CR4]). Meanwhile, p115 also binds giantin on COPI vesicles and works with GM130 on Golgi membranes to provide a bridging role for vesicle tethering (Sonnichsen et al. [@CR269]). Thus, GM130 and p115 are two major tethering factors in ER-to-Golgi trafficking (Munro [@CR189]).

Other than the well-studied GRASP65-GM130 and GM130-p115-giantin complexes, the GRIP domain containing golgins are another group of proteins associated with the Golgi structure. Most GRIP domain-containing golgins localize to the TGN via their GRIP domains and are involved in Golgi organization (Luke et al. [@CR161]). GCC185 is reported to localize independently of Arl1 on TGN and plays an essential role in Golgi structure formation. Depletion of GCC185 results in fragmentation of both *cis-* and *trans-*Golgi that are dispersed throughout the cytoplasm (Derby et al. [@CR55]). On the other hand, another TGN golgin GCC88 is reported to play a role in TGN organization and ribbon-linking. Overexpression of GCC88 causes a loss of the compact Golgi ribbon and dispersal of mini-stacks throughout the cytoplasm, while knockdown of GCC88 results in a longer ribbon structure (Gosavi et al. [@CR90]). A recent report suggests that GCC88-induces Golgi ribbon dispersal via actin and non-muscle myosin IIA. In addition, a novel GCC88-binding partner, the long isoform of intersectin-1 (ITSN-1), a guanine nucleotide exchange factor for Cdc42, is identified to be involved in this process (Makhoul et al. [@CR168]).

Other Golgi Structure-Related Proteins {#Sec5}
--------------------------------------

Besides the Golgi matrix proteins and their cofactors described above, other proteins including SNAREs, kinases, methyltransferases, and GTPases have also been reported to be related to Golgi structural organization and function. A few examples are discussed below.

Vesicle-associated membrane protein 4 (VAMP4), a v-SNARE protein located on the TGN, was first shown to play a role in retrograde trafficking from early endosomes to the TGN (Steegmaier et al. [@CR271]). It was later reported that depletion of VAMP4 led to fragmentation of the Golgi ribbon, although Golgi membranes remained in the juxtanuclear area. EM studies revealed shortened Golgi stacks with a normal arrangement. Depletion of the cognate SNAREs of VAMP4, syntaxin 6, syntaxin 16, and Vti1a also disrupted the Golgi ribbon. These findings suggest that the maintenance of the Golgi ribbon structure requires normal retrograde trafficking, which is likely mediated by the formation of VAMP4-containing SNARE complexes (Shitara et al. [@CR254]).

Serine/threonine-protein kinase H1 (PSKH1) was primarily characterized with multiple intracellular localizations, including Brefeldin A-sensitive Golgi compartment, centrosomes, nucleus, and cytoplasm (Brede et al. [@CR28]). PSKH1 targeting to Golgi depends on dual N-terminal acylation, myristoylation on glycine 2, and palmitoylation on cysteine 3. Expression of palmitoylation site mutant PSKH1 results in the disassembly of the Golgi apparatus to a diffused cytoplasmic pattern without interrupting the microtubule cytoskeleton (Brede et al. [@CR29]). The substrates of this kinase on the Golgi are so far unidentified.

Protein arginine methyltransferase 5 (PRMT5) localizes to the Golgi apparatus and forms complexes with several components, including GM130, which was later identified as a substrate of PRMT5. N-terminal methylation of GM130 does not affect its Golgi localization but is critical for Golgi ribbon formation. Depletion of PRMT5 and expression of methylation-defective GM130 mutants result in fragmentation and dispersal of the Golgi ribbon (Zhou et al. [@CR343]).

In addition to the proteins mentioned above, Rab small GTPases are another group of key regulators of mammalian Golgi organization. Many Rab proteins, including but not limited to Rab1, Rab2 and Rab8 (Aizawa and Fukuda [@CR2]), Rab18 and Rab43 (Dejgaard et al. [@CR52]), Rab6/41 (Goud et al. [@CR91]; Martinez et al. [@CR172]; Liu et al. [@CR151]), and Rab30 (Kelly et al. [@CR126]), have been shown to play a role in Golgi structure organization and reviewed previously in detail (Goud et al. [@CR92]). Considering that Rab proteins switch between inactive GDP-bound and active GTP-bound forms, it has been proposed that Golgi organization-related Rab proteins are divided into two categories. With Class 1 Rabs, the Golgi ribbon is disrupted by Rab inactivation but appears normal with overexpression, whereas with Class 2 Rabs, Rab inactivation has little effect on Golgi ribbon organization, while overexpression leads to the redistribution of Golgi enzymes to the ER (Liu and Storrie [@CR150]). These results indicate that Rabs control the Golgi structure through modulating membrane tethering and trafficking.

Golgi Dynamics in the Mammalian Cell Cycle {#Sec6}
==========================================

The Golgi undergoes a series of sophisticated cell cycle-dependent disassembly and reassembly processes, including the deformation and reformation of Golgi ribbon, stacks, and cisternae. At the onset of mitosis, the Golgi ribbon unlinks into ministacks, which further undergo unstacking and vesiculation. These processes ensure the equal distribution of Golgi compartments into the two daughter cells (Wang [@CR301]; Wei and Seemann [@CR310]). In telophase, the Golgi vesicles fuse into cisternae and form stacks. The new stacks then accumulate in the perinuclear region and further link into a ribbon. The molecular factors that control these processes include Golgi matrix proteins, kinases and phosphatases, ubiquitin ligases and deubiquitinating enzymes, vesicle budding and fusion factors, and actin and microtubule cytoskeleton. An in vitro system has been developed to replicate the Golgi disassembly and reassembly process through sequential treatments of purified Golgi membranes with mitotic (MC) and interphase (IC) cytosol, or with purified proteins (Tang et al. [@CR280], [@CR281]). This system provides a powerful tool for testing key proteins in Golgi structure formation, which makes it possible to identify the minimal machinery and key components that control mitotic Golgi disassembly and post-mitotic reassembly (Huang and Wang [@CR113]).

Mechanisms of Golgi Disassembly and Reassembly in the Mammalian Cell Cycle {#Sec7}
--------------------------------------------------------------------------

The first step of Golgi disassembly at the onset of mitosis is Golgi ribbon unlinking. At this step, Golgi stacks in the ribbon are disconnected and dispersed. This step involves disconnecting the tubules between the stacks by the membrane fission protein CtBP/BARS, which is crucial for G2/M transition (Hidalgo Carcedo et al. [@CR107]; Colanzi et al. [@CR46]). Further, GRASPs undergo mitotic phosphorylation which are also required for ribbon-unlinking. The extracellular-signal-regulated kinase (ERK) directly phosphorylates GRASP55 and blocks its activity in both Golgi ribbon formation and *trans*-oligomerization (Feinstein and Linstedt [@CR69]), while GRASP65 is phosphorylated by c-Jun N-terminal kinase (JNK) on Serine 277 (S277), which causes the separation of the Golgi stacks (Cervigni et al. [@CR37]).

Sequential phosphorylation of GRASP65 on multiple sites by cyclin-dependent kinase 1 (Cdk1) and polo-like kinase 1 (Plk1) results in its conformational changes and subsequent de-oligomerization (Lin et al. [@CR146]; Preisinger et al. [@CR218]; Wang et al. [@CR303]; Tang et al. [@CR284]; Vielemeyer et al. [@CR296]). On the other hand, GRASP55 is phosphorylated by ERK and partially by Cdk1 (Xiang and Wang [@CR319]). In addition to the unique phosphorylation sites in the SPR domains of GRASPs, S189 within the GRASP domain of GRASP65 is modified by Plk1, which causes conformational change and impaired self-association (Sengupta and Linstedt [@CR251]). An in vivo membrane-tethering activity assay using a construct of full-length GRASP55 fused to the C-terminal mitochondrial anchoring sequence shows that the tethering activity is diminished by introducing a phosphomimic S189D mutant. This result suggests that S189 might be a Plk1 target site on both GRASPs, although direct evidence remains to be provided (Truschel et al. [@CR289]). GRASP65 is dephosphorylated by PP2A in late mitosis and the *trans-*oligomer reformation is therefore rehabilitated to promote cisternae stacking (Tang et al. [@CR280]).

The unstacked cisternae further disassemble into vesicles, which depends on COPI vesicle formation and blockage of vesicle docking and membrane fusion. As mentioned above, the GM130-p115-giantin complex promotes COPII vesicle docking to the Golgi. Cdk1 phosphorylation of GM130 on S25 during mitosis inhibits p115-interaction and therefore blocks vesicle docking (Lowe et al. [@CR155]). Inhibition of Cdk1 causes Golgi vesiculation failure, suggesting an essential role of Cdk1 activity in mitotic Golgi vesiculation. However, expression of the GM130 S25A non-phosphorylatable mutant in GM130-depleted cells causes no apparent defects in Golgi vesiculation and mitotic progression, indicating the existence of GM130 S25 phosphorylation-independent pathways that ensure Golgi vesiculation and mitotic progression in mammalian cells (Sundaramoorthy et al. [@CR274]).

Recently, the recruitment and activation of Aurora kinase family member Aurora A at the centrosomes in M phase was reported to depend on Golgi ribbon unlinking in G2 phase (Barretta et al. [@CR21]). Aurora A functions in centrosome maturation, mitotic entry, and bipolar spindle formation during mitosis (Nikonova et al. [@CR199]; Carmena et al. [@CR35]; Kimura et al. [@CR128]). This finding indicates a potential link between Aurora A activity and cell cycle-associated Golgi structure modulation. Indeed, it was later confirmed that knockdown or inhibition of Aurora A induces Golgi dispersal without affecting the GM130 protein level in interphase. Further investigation revealed that interference of Aurora A causes Golgi dispersal only after mitosis via the dissociation of the Golgi and centrosome (Kimura et al. [@CR129]). These studies revealed a novel relationship between G2 phase Golgi unlinking, M phase Aurora A activation, and interphase Golgi structure formation.

Post-mitotic Golgi Membrane Fusion and Its Regulation {#Sec8}
-----------------------------------------------------

Two AAA ATPases, NSF and p97/VCP, are involved in membrane fusion during post-mitotic Golgi reassembly, and their activities are regulated by phosphorylation during mitosis (Rabouille et al. [@CR224]). For NSF-catalyzed fusion, the p115-GM130 tethering complex is disrupted by GM130 phosphorylation during mitosis (Lowe et al. [@CR155]), while post-mitotic phosphorylation of p115 by a casein kinase II (CKII)-like enzyme is required for cisterna reassembly (Dirac-Svejstrup et al. [@CR59]). Contemporarily, homotypic fusion of Golgi membranes mediated by p97 is also blocked upon phosphorylation of p47 and p37. p97 uses these two distinct cofactors for its membrane fusion function: p47 is essential for the regrowth of Golgi cisternae from mitotic Golgi fragments (Kondo et al. [@CR134]), while p37 is required for the maintenance of the Golgi structure in interphase as well as for its reassembly in late mitosis (Uchiyama et al. [@CR292]). Both pathways are regulated by Cdk1-mediated phosphorylation. Phosphorylation of p47 on S140 abolishes its binding to Golgi membranes, resulting in mitotic inhibition of the p97/p47 pathway (Uchiyama et al. [@CR291]). Phosphorylation on S56 and Threonine 59 (T59) disables p37 from binding to Golgi membranes and consequently blocks p97/p37-mediated Golgi membrane fusion at late mitosis (Kaneko et al. [@CR124]).

In addition to phosphorylation, p97/p47-mediated Golgi membrane fusion is also regulated by ubiquitination (Tang and Wang [@CR279]). Tang et al. discovered that the Homologous to the E6-AP Carboxyl Terminus (HECT) domain containing ubiquitin ligase HACE1 is targeted to the Golgi membrane through the interaction with Rab1 and participates in post-mitotic Golgi biogenesis (Tang et al. [@CR283]). Depletion of HACE1 or expression of an inactive mutant impairs post-mitotic Golgi membrane fusion. The identification of HACE1 as a Golgi-localized ubiquitin ligase provides evidence that ubiquitin has a critical role in Golgi biogenesis during the cell cycle (Tang et al. [@CR283]). Later, the Golgi t-SNARE syntaxin 5 was identified as a ubiquitination substrate (Huang et al. [@CR114]). Syntaxin 5 is monoubiquitinated by HACE1 in early mitosis and deubiquitinated by the de-ubiquitinase VCIP135 in late mitosis (Wang et al. [@CR304]). The monoubiquitination of syntaxin 5 at Lysine 270 (K270) in the SNARE domain impairs the interaction between syntaxin 5 and the cognate v-SNARE Bet1 but increases its binding to the p97 adaptor p47 through the UBA domain of p47, which is required for post-mitotic Golgi membrane fusion (Meyer et al. [@CR179]). Expression of the syntaxin 5 K270R mutant in cells impairs post-mitotic Golgi reassembly. Therefore, monoubiquitinated syntaxin 5 recruits p97/p47 to the mitotic Golgi fragments and promotes post-mitotic Golgi reassembly upon ubiquitin removal by VCIP135 (Huang et al. [@CR114]). VCIP135 was originally identified as a p97 interacting protein (Kano et al. [@CR125]). It was later shown to be a de-ubiquitinating (DUB) enzyme involved in p97/p47-mediated membrane fusion (Wang et al. [@CR304]). VCIP135 DUB activity, as well as its interaction with p97 and association with Golgi membranes, is regulated by phosphorylation (Zhang and Wang [@CR332]; Zhang et al. [@CR337]). In mitosis, VCIP135 is phosphorylated at S130 by Cdk1 and thus is inactivated, allowing syntaxin 5 to be ubiquitinated by HACE1; in telophase, VCIP135 is dephosphorylated and reactivated, removing ubiquitin from syntaxin 5 to allow p97-mediated membrane fusion (Huang and Wang [@CR113]; Wang [@CR301]). These studies revealed a novel mechanism that monoubiquitination regulates Golgi membrane dynamics during the mammalian cell cycle.

Golgi Stress Response {#Sec9}
=====================

As stated above, the Golgi apparatus in mammalian cells forms a unique stacked structure under normal growth conditions, which undergoes a regulated disassembly and reassembly process during the cell cycle. However, the Golgi structure and function could be impaired under stress conditions, such as DNA damage, energy and nutrient deprivation, and pro-apoptotic conditions. This could be attributed to perturbation of microtubule organization or phosphorylation, degradation, or cleavage of Golgi structural proteins. Additionally, many signaling molecules have been identified to be associated with the Golgi. Thus, it has been proposed that the Golgi could sense and transduce stress signals and therefore serves as a hub in the cellular signaling network (Farhan and Rabouille [@CR68]; Mayinger [@CR177]; Makhoul et al. [@CR168]).

Apoptotic Stress and Golgi Fragmentation {#Sec10}
----------------------------------------

Apoptosis, also known as programmed cell death, is a cell suicide mechanism carried out by organelle-directed regulators such as the Bcl-2 proteins and ultimately executed by the caspase family proteases (Nicholson and Thornberry [@CR198]). Organellar response to apoptotic initiation includes death receptor endocytosis, mitochondrial and lysosomal permeabilization, ER calcium release, and Golgi fragmentation. The Golgi is one of the first organelles to be affected during apoptosis (Mukherjee et al. [@CR188]; Aslan and Thomas [@CR12]). During apoptosis, several Golgi matrix proteins related to Golgi structure maintenance are cleaved by caspases, leading to Golgi fragmentation (Hicks and Machamer [@CR106]). Apoptotic Golgi fragmentation is one of the most extensively studied Golgi stress responses. Reported caspases-cleaved Golgi proteins include GRASP65, golgin-160, GM130, p115, syntaxin 5, and giantin (Lane et al. [@CR138]; Mancini et al. [@CR170]; Walker et al. [@CR299]; Chiu et al. [@CR43]; Lowe et al. [@CR156]; Machamer [@CR166]), as summarized in Table [19.2](#Tab2){ref-type="table"} and discussed below.Table 19.2Apoptotic cleavage of Golgi proteinsNamesApoptosis inducerCaspasesCleavage siteGolgi structural changeGolgin-160STS; CH11Caspase-2, 3 and 7D59, D139, D311Golgi fragmentation (Mancini et al. [@CR170]; Mukherjee et al. [@CR188]; Nozawa et al. [@CR203]; Hicks and Machamer [@CR105]; Maag et al. [@CR164])GRASP65Anisomycin; STSCaspase-3D320, D375, D393Golgi fragmentation (Lane et al. [@CR138]; Cheng et al. [@CR39])p115STS; 4-hydroxytamoxifen; CH11; CACaspase-3 and 8D757Golgi fragmentation (Chiu et al. [@CR43]; How and Shields [@CR109]; Mukherjee et al. [@CR188]; Mukherjee and Shields [@CR187]; Woldemichael et al. [@CR317])GM130CH11Caspase-3--Golgi fragmentation (Walker et al. [@CR299]; Lowe et al. [@CR156]; Mukherjee et al. [@CR188])Syntaxin 5STS; anisomycinCaspase-3D1882, D1083Secretion inhibition (Lowe et al. [@CR156])GiantinSTS; anisomycinCaspase-3D263Secretion inhibition (Lowe et al. [@CR156]; Nozawa et al. [@CR203])*CA* carminomycin I, *CH11* an anti-Fas monoclonal antibody, *D* aspartic acid, *STS* staurosporine

### Golgin-160 {#Sec11}

Golgin-160 is a golgin that plays a role in vesicle tethering and trafficking (Misumi et al. [@CR181]). It is cleaved by caspase-2, caspase-3, and caspase-7 during apoptosis. Under pro-apoptotic conditions stimulated by staurosporine, the Golgi senses and transduces apoptotic signals using a local caspase, caspase-2. Caspase-2 is special in a way that it has both the property of initiator caspases and the substrate specificity of executioner caspases (Mancini et al. [@CR170]). Although it is unclear how caspase-2 is activated by pro-apoptotic signals, in vitro and in vivo caspase cleavage assays showed that caspase-2 cleavage of golgin-160 at aspartate 59 (D59) happens prior to golgin-160 cleavage by caspase-3 and 7 at D139 and D311 (Mancini et al. [@CR170]). Expression of the D59A cleavage-defective mutant of golgin-160 delays Golgi disintegration under staurosporine treatment (Machamer [@CR165]; Hicks and Machamer [@CR106]).

Subsequently, it was shown that an N-terminal 85 amino acid fragment of golgin-160 contains both a Golgi localization signal and a nuclear localization signal (Hicks and Machamer [@CR105]). Expression of a non-cleavable golgin-160 mutant inhibits ER stress or ligation of death receptor-induced apoptosis (Maag et al. [@CR164]). Latterly, yeast two hybrid screening revealed that GCP60 preferentially binds to one of the caspase cleavage products of golgin-160, aa 140-311, to inhibit its nuclear localization (Sbodio et al. [@CR245]). Overexpression of GCP60 sensitizes cells to staurosporine-induced apoptosis, while nuclear localization of a golgin-160 apoptotic cleavage fragment (aa 140-311) protects cells from apoptosis. However, another report indicates that golgin-160 depletion does not affect the Golgi morphology nor constitutive secretion (Williams et al. [@CR315]). Therefore, the mechanism of how golgin-160 transduces apoptotic signals and regulates the apoptotic response needs to be further studied.

### GRASP65 {#Sec12}

GRASP65 is cleaved in apoptosis induced by oxygen- and glucose-deprivation (OGD) as in ischemia-induced cerebral vascular endothelial injury (Yin et al. [@CR328]) and in staurosporine- or Fas ligand-induced apoptosis (Lane et al. [@CR138], Cheng et al. [@CR39]). In apoptosis, GRASP65 is cleaved by caspase-3 on D320, D375, and D393. Expression of a cleavage-resistant form of GRASP65 delays Golgi fragmentation in apoptosis and protects cells from Fas/CD95-mediated apoptosis, whereas expression of an N-terminal caspase-cleaved fragment dramatically sensitizes cells to Fas/CD95-mediated apoptosis (Lane et al. [@CR138], Cheng et al. [@CR39]). Further results revealed that the C-terminal fragments of GRASP65 produced by caspase cleavage promotes Fas/CD95-mediated apoptosis via being targeted to mitochondria by binding to Bcl-X~L~ (Cheng et al. [@CR39]). However, the mechanism of how the C-terminal cleavage fragment of GRASP65 regulates apoptosis at the mitochondria and the role of Bcl-X~L~ in this process are still unknown. The Golgi fragmentation phenotype induced by apoptotic GRASP65 cleavage is similar to that of GRASP65 phosphorylation in mitosis (Warren [@CR309]). There is evidence that several kinases involved in mitotic GRASP65 phosphorylation such as Cdk1 and ERK are activated during apoptosis and regulate apoptosis by phosphorylating caspase and Bcl-2 family proteins (Terrano et al. [@CR286]; Yamaguchi et al. [@CR324]; Lu et al. [@CR159]). Whether these kinases directly regulate apoptotic Golgi fragmentation by phosphorylating GRASP65 or other Golgi proteins remains unclear (Ji et al. [@CR117]).

### p115 {#Sec13}

The ER-to-Golgi membrane tether, p115, is cleaved by caspase-3 and caspase-8 during apoptosis. Expression of a caspase-resistant form of p115 delays Golgi fragmentation in apoptosis. Exogenous expression of a p115 C-terminal apoptotic fragment leads to apoptosis and Golgi fragmentation (Chiu et al. [@CR43]). The extreme C-terminal fragment, generated by caspase cleavage during apoptosis, translocates into the nucleus and further activates the apoptosis machinery. Interestingly, translocation of the p115 C-terminal fragment happens prior to major Golgi structural changes, indicating it as an early event (Mukherjee and Shields [@CR187]). The p115 C-terminus is SUMOylated, which regulates its nuclear translocation and amplification of apoptosis signals in a p53-dependent manner (How and Shields [@CR109]; Mukherjee and Shields [@CR187]). In a high-throughput screen, Carminomycin I (CA) was discovered to inhibit cell proliferation of Von Hippel-Lindau (VHL) defective Clear Cell Renal Cell Carcinoma (*VHL*−/− CCRCC) (Woldemichael et al. [@CR317]). CA activates caspase-2 and caspase-3 to cleave p115, which inhibits CCRCC proliferation (Woldemichael et al. [@CR317]).

### Other Proteins {#Sec14}

Several other Golgi structural proteins are also involved in apoptosis or cleaved by caspases. The level of GM130 is reduced during Fas-mediated apoptosis but not in staurosporine-induced apoptosis (Walker et al. [@CR299]). However, it is not clear whether the reduction is due to GM130 cleavage or degradation. Syntaxin 5 and giantin are also cleaved by caspase-3 during apoptosis, which inhibits ER-to-Golgi transport (Lowe et al. [@CR156]). Golgin-95 and golgin-97 are cleaved during necrosis but not apoptosis (Nozawa et al. [@CR203]). Cleavage of golgin-95 and golgin-97 during necrosis is also caspase-dependent, since pretreatment of the cells with pan-caspase inhibitor, zVAD-fmk, abolished the cleavage of these two proteins (Nozawa et al. [@CR203]).

Some of the Golgi proteins are also reported to regulate apoptosis. The Golgi SNARE GS28 is involved in cisplatin-induced apoptosis in a p53-dependent manner (Sun et al. [@CR273]). Overexpression of GS28 sensitizes HEK293 cells to the apoptosis-inducer cisplatin via the accumulation of p53 and Bax and the stimulation of p53 pro-apoptotic phosphorylation at S46. It was also shown that GS28 forms a complex with the p53 ubiquitin E3 ligase Murine Double Minute 2 (MDM2) to inhibit its function and consequential p53 ubiquitination and degradation (Sun et al. [@CR273]). Therefore, GS28 promotes cisplatin-induced apoptosis by stabilizing and regulating pro-apoptotic phosphorylation of p53.

A well-studied mediator of intracellular vesicle fusion, NSF attachment protein α (αSNAP), has been reported to have pro-survival functions (Naydenov et al. [@CR194]). Depletion of αSNAP triggers apoptosis in epithelial cells by reducing the anti-apoptotic protein Bcl-2. Depletion of αSNAP in p53 null or Bax null cells still results in apoptosis, indicating that the anti-apoptotic function is independent of p53 and Bax. Interestingly, αSNAP depletion induces apoptosis independent of the cleavage of Golgi proteins such as GRASP65, golgin-160, and p115 but rather by dysregulation of ER-Golgi vesicle cycling and possibly through ER stress (Naydenov et al. [@CR194]). Some other Golgi proteins, including human Golgi anti-apoptotic protein (h-GAAP) (Gubser et al. [@CR95]; Saraiva et al. [@CR241]) and Golgi integral membrane protein 4 (GOLIM4) (Bai et al. [@CR16]), are also reported to have anti-apoptotic functions. GOLIM4 is overexpressed in some head and neck cancers, and depletion of GOLIM4 reduces cell proliferation and cell viability by inducing apoptosis (Bai et al. [@CR16]).

Although microtubule and actin filaments play important roles in Golgi orientation and structure, Golgi fragmentation in apoptosis occurs prior to cytoskeleton disorganization (Mukherjee et al. [@CR188]; Yadav and Linstedt [@CR322]). Furthermore, the level of actin and tubulin did not change during apoptosis, while Golgi structural proteins are cleaved as discussed above. Therefore, Golgi fragmentation in early apoptosis is independent of microtubule and actin filament disorganization.

GOLPH3 and DNA Damage-Induced Golgi Fragmentation {#Sec15}
-------------------------------------------------

The Golgi phosphoprotein 3 (GOLPH3) is a peripheral membrane protein that regulates vesicle budding and TGN-to-plasma membrane trafficking (Dippold et al. [@CR58]). GOLPH3 is localized to the TGN by binding to phosphatidylinositol 4-phosphate (PI4P). Depletion of PI4P leads to GOLPH3 dissociation from the TGN. GOLPH3 also binds to the actin-based motor protein MYO18A to link Golgi membranes with the actin cytoskeleton. This bridging effect creates a tension required for vesicle budding, trafficking, and maintenance of the Golgi ribbon. Depletion of GOLPH3 or MYO18A leads to the loss of the tensile force, resulting in the shrinkage of the Golgi ribbon and a reduction of vesicles formed at the TGN (Dippold et al. [@CR58]; Bishe et al. [@CR25]; Ng et al. [@CR197]). GOLPH3 is an oncogene known to be overexpressed in some solid tumors, including lung cancer and breast cancer (Scott et al. [@CR247]; Zeng et al. [@CR331]). It is also reported that GOLPH3 increases cell proliferation and cell size by regulating cell proliferation through the interaction with the retromer complex and activation of the mammalian target of rapamycin mTOR (Scott et al. [@CR247]). GOLPH3 induces cell proliferation in breast cancer cells by inhibiting the tumor suppressor transcription factor FOXO1 through activating AKT (Zeng et al. [@CR331]). These findings demonstrate that a *trans*-Golgi protein can serve as an oncogene (Scott et al. [@CR247]; Buschman et al. [@CR32]; Kuna and Field [@CR136]).

Interestingly, DNA damage causes Golgi dispersal in a GOLPH3-dependent manner. DNA damage activates the DNA-PK kinase to phosphorylate GOLPH3 on T143/T148, which aberrantly increases the tensile force for the Golgi to fragment. Golgi fragmentation in this scenario increases cell survival with an unknown mechanism (Farber-Katz et al. [@CR67]). Depletion of GOLPH3 or MYO18A increases cancer cells' sensitivity to DNA damage inducing agents, suggesting that GOLPH3 phosphorylation-induced Golgi fragmentation may serve as a protective mechanism (Farber-Katz et al. [@CR67]). Considering that GOLPH3 is overexpressed in many solid tumors, it is reasonable to speculate that this may be a mechanism of how cancer cells escape DNA damage-induced apoptosis (Farber-Katz et al. [@CR67]; Buschman et al. [@CR32]; Li et al. [@CR144]).

In addition to its high expression level in some cancer cells, GOLPH3 overexpression is also reported in mouse N2A cells under oxygen-glucose deprivation and reoxygenation (OGD/R), a model mimicking severe oxidative injury (Li et al. [@CR143]). In this OGD/R model, GOLPH3 is overexpressed and forms puncta in the cytosol, which induces the formation of reactive oxygen species (ROS) and lipidation of LC3. Opposed to its anti-apoptotic role in cancer cells, depletion of GOLPH3 in OGD/R desensitizes the cells to apoptosis (Li et al. [@CR143]).

Golgi in Autophagy Regulation {#Sec16}
-----------------------------

Most recently, the Golgi stacking protein GRASP55 was reported to regulate autophagy upon energy deprivation (Zhang et al. [@CR340]; Zhang and Wang [@CR335], [@CR336]). Under normal growth condition, GRASP55 is O-GlcNAcylated and localizes in the *medial-* and *trans-*Golgi for stacking. However, under glucose starvation, a pool of de-O-GlcNAcylated GRASP55 translocates to the interface between autophagosomes and lysosomes to facilitate autophagosome-lysosome fusion. After a short-term energy deprivation, the Golgi structure is only mildly affected, possibly due to sufficient GRASP55 molecules remaining in the Golgi to maintain its structure. Among over a dozen Golgi proteins tested, only GRASP55, but not GRASP65, GM130, or golgin-45, is O-GlcNAcylated under growth conditions and targets to autophagosomes upon energy deprivation, indicating that GRASP55 serves as an energy sensor on the Golgi to regulate both intracellular trafficking and autophagy. Significantly, the same scenario may be seen in autophagy induced by amino acid starvation and inhibition of mTOR (Zhang et al. [@CR340]).

In addition to Golgi fragmentation, GCC88 overexpression also induces autophagy via reducing the activity of mTOR. A considerable pool of mTOR is localized and activated on the Golgi, which is dependent on the ribbon structure for recruitment but independent of lysosomal mTOR activation (Gosavi et al. [@CR90]). These findings indicate the Golgi ribbon as an important location for the functional regulation of mTOR activity.

Additionally, autophagosomes may directly form on Golgi membranes (Guo et al. [@CR96]) or obtain membranes from the Golgi (Geng et al. [@CR83]; Geng and Klionsky [@CR82]). The only recognized transmembrane ATG protein, ATG9, localizes at the *trans*-Golgi network and late endosomes and is essential for autophagosome formation (Yamamoto et al. [@CR325]), although the detailed mechanism awaits further investigation (Orsi et al. [@CR205]). Recently, the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) is proposed to serve as a key membrane source for autophagosome formation (Ge et al. [@CR80]). Under normal condition, COPII vesicles are generated from the ER-exit sites (ERES) for ER-Golgi membrane trafficking, while upon starvation, the COPII assembly activator Prolactin Regulatory Element-Binding protein (PREB)/SEC12 relocates to the ERGIC and triggers ERGIC-COPII vesicle formation as membrane templates for LC3 lipidation.

Alteration of Golgi Structure and Function in Diseases {#Sec17}
======================================================

Golgi structure defects and dysfunctions have been observed in many diseases, including pathogen infection, neurodegenerative diseases, and cancer (Aridor and Hannan [@CR11]). Generally, the mechanisms of Golgi fragmentation include imbalanced membrane flux, altered microtubule dynamics, and posttranslational modifications or proteolytic cleavage of Golgi structural proteins (Wei and Seemann [@CR311]). In many cases, the correlation between Golgi defect and disease progression is unclear. A few interesting cases reported recently are discussed below.

Alzheimer's Disease (AD) {#Sec18}
------------------------

AD is an age-related neurodegenerative disease of the central nerve system characterized by progressive loss of cognition and memory. Golgi fragmentation occurs in neurons of patients with AD since the earliest stages of disease development (Sundaramoorthy et al. [@CR275]). Some cases of early-onset AD are related to mutations in the Amyloid Precursor Protein (APP) or Presenilin 1 and 2 (PSN1 and 2). The amyloid-beta (Aβ) peptide is a proteolytic product of APP, which is considered to be the major inducer of AD (Selkoe and Hardy [@CR250]). Aβ accumulation is likely the direct cause of Golgi fragmentation, as Aβ-treatment causes reversible Golgi fragmentation in cultured neurons (Joshi et al. [@CR122]).

Present research supports that activation of Cyclin-dependent kinase 5 (Cdk5) by Aβ accumulation via the \[Ca^2+^\]-calpain-p25 pathway may be the major trigger of Golgi fragmentation in AD (Lee and Linstedt [@CR141]; Joshi et al. [@CR123]; Joshi and Wang [@CR121]; Evin [@CR65]; Ayala and Colanzi [@CR15]). Cdk5 may function in two ways. First, Cdk5 phosphorylates GM130 at S25 and inhibits its interaction with the Golgi tethering protein p115 (Sun et al. [@CR272]). Second, Cdk5 phosphorylates GRASP65 at T220/T224, which inhibits GRASP65 function in Golgi stack formation and ribbon linking (Joshi et al. [@CR122]). Furthermore, inhibiting Cdk5 or expressing non-phosphorylatable GRASP65 mutants both rescued the Golgi structure and reduced Aβ secretion by elevating the α-cleavage of APP (Joshi and Wang [@CR121]; Joshi et al. [@CR122]), indicating that GRASP65 phosphorylation may be the main reason for AD-induced Golgi fragmentation. These studies not only provide molecular mechanisms for Golgi fragmentation but also suggest Golgi as a potential drug target for AD treatment (Joshi et al. [@CR123]; Joshi and Wang [@CR121]; Ayala and Colanzi [@CR15]).

Amyotrophic Lateral Sclerosis (ALS) {#Sec19}
-----------------------------------

ALS is a fatal neurodegenerative disorder specifically targeted to motor neurons. Fragmented Golgi has been observed in numerous models of [superoxide dismutase 1](https://www.sciencedirect.com/topics/neuroscience/copper-zinc-superoxide-dismutase) (SOD1), TDP-43, FUS, and optineurin-associated ALS (Fujita et al. [@CR77]; Soo et al. [@CR270]; Van Dis et al. [@CR294]; Wallis et al. [@CR300]). SOD1 inhibits ER-to-Golgi transport and causes Golgi fragmentation (Atkin et al. [@CR13]) by reducing the β-COP protein level, accumulating the ER-Golgi v-SNAREs GS15 and GS28, and destabilizing microtubules by the upregulation of Stathmins 1 and 2 (Bellouze et al. [@CR23]; Atkin et al. [@CR13]). FUS and TDP-43 impair the incorporation of secretory cargo into COPII vesicles (Soo et al. [@CR270]). Furthermore, expression of ALS-related optineurin mutants impairs myosin VI-mediated protein trafficking from Golgi to plasma membrane, which also induces Golgi fragmentation (Sundaramoorthy et al. [@CR275]). Conclusively, impairment of distinct protein trafficking pathways by different ALS-linked proteins are specific triggers for Golgi fragmentation in ALS.

Parkinson's Disease (PD) {#Sec20}
------------------------

PD is pathologically characterized by the loss of dopamine-containing neurons and by the formation of intracellular protein aggregates known as Lewy bodies in which α-synuclein has been recognized as a major constituent (Forno [@CR71]; Wakabayashi et al. [@CR298]). Golgi fragmentation can be detected in early-stage PD brains (Fujita et al. [@CR76]) and is strongly correlated to the presence of prefibrillar α-synuclein (Gosavi et al. [@CR89]). Since then, emerging studies have provided important insights into the mechanisms of how α-synuclein causes pathological Golgi fragmentation and neuronal degeneration. The primary effect of α-synuclein aggregation is the inhibition of ER-to-Golgi transport (Lashuel and Hirling [@CR139]), which can be rescued by the overexpression of Rab1 and Rab8 and depletion of Rab2 and syntaxin 5 (Rendon et al. [@CR232]; Coune et al. [@CR47]). In a most recent report, mutations in the leucine-rich repeat kinase 2 (LRRK2), a major genetic cause of autosomal-dominantly inherited PD, markedly enhance Rab7L1 phosphorylation on S72, resulting in TGN fragmentation (Fujimoto et al. [@CR75]).

Cancer {#Sec21}
------

Golgi disorganization may be related to cancer progression and metastasis in the following aspects: aberrant glycosylation, abnormal expression of Ras GTPase, dysregulation of kinases, and hyperactivation of myosin motor proteins (Petrosyan [@CR215]). Perturbation of the Golgi morphology in cancers results in an increase of sialylation which is associated with a metastatic cell phenotype (Schultz et al. [@CR246]). Overexpression of sialylated antigens is significantly correlated with tumor progression and therapy resistance due to an anti-apoptotic effect (Lee et al. [@CR142]; Park et al. [@CR211]; Petrosyan et al. [@CR216]). Over-activation of Rabs, which coordinate with golgins in protein transportation and Golgi structure maintenance, has been reported in different types of cancers (Goldenring [@CR88]). Furthermore, Golgi disorganization-related kinases, including Src, ERK9, and P21-activated protein kinase (Pak1), are found elevated in tumor cells (Chia et al. [@CR41]; Ching et al. [@CR42]; Weller et al. [@CR313]). The ubiquitin ligase HACE1, which regulates p97-mediated Golgi membrane fusion as discussed above, is reported as a tumor suppressor downregulated in multiple tumors including Wilms' tumor (Anglesio et al. [@CR10]), resulting in Golgi fragmentation (Tang et al. [@CR283]; Cui and Wang [@CR49]). Additionally, hyperactivation of Golgi-associated myosins, including MYO18A that directly binds to GOLPH3 to promote Golgi dispersal (Dippold et al. [@CR58]; Allan et al. [@CR5]), is detected in many aggressive cancers. Golgi fragmentation is one of the essential and earliest events in apoptosis, where several golgins and GRASP65 are cleaved by activated caspases, as described in previous sections.

Viral Infection {#Sec22}
---------------

Several membrane structures including the Golgi are used by viruses as viral factories to replicate, concentrate, and assemble the viral genome and proteins into viral particles (Miller and Krijnse-Locker [@CR180]; Netherton et al. [@CR195]; Salonen et al. [@CR240]). As a highly dynamic organelle, Golgi serves as a membrane scaffold for multiple viruses, including infectious [hepatitis C virus](https://www.sciencedirect.com/topics/medicine-and-dentistry/hepatitis-c-virus), enteroviruses, poliovirus, [foot-and-mouth-disease virus](https://www.sciencedirect.com/topics/medicine-and-dentistry/foot-and-mouth-disease-virus), dengue virus, coronavirus, Kunjin virus, [tick-borne encephalitis virus](https://www.sciencedirect.com/topics/medicine-and-dentistry/tick-borne-encephalitis-virus), rubella virus, and bunyamwera virus (Miller and Krijnse-Locker [@CR180]; Harak and Lohmann [@CR99]; Risco et al. [@CR234]; Salanueva et al. [@CR239]; Delgui et al. [@CR53]; Westerbeck and Machamer [@CR314]), and is frequently fragmented after infection (Campadelli et al. [@CR33]; Salanueva et al. [@CR239]; Yadav et al. [@CR323]; Avitabile et al. [@CR14]; Lavi et al. [@CR140]; Hansen et al. [@CR97]; Rebmann et al. [@CR229]). Viruses use Golgi membranes directly and/or hijack master controllers of Golgi biogenesis and trafficking to generate vesicles that are used as the site of viral RNA replication (Quiner and Jackson [@CR221]; Hansen et al. [@CR97]; Short et al. [@CR256]), wrapping (Sivan et al. [@CR263]; Alzhanova and Hruby [@CR8]; Alzhanova and Hruby [@CR7]; Nanbo et al. [@CR193]; Lundu et al. [@CR162]; Procter et al. [@CR219]), intracellular transduction (Nonnenmacher et al. [@CR202]), and secretion (Zhang et al. [@CR339]). Viral infection triggers Golgi fragmentation via diverse mechanisms, ranging from phosphorylating key Golgi structural proteins such as GRASP65 (Rebmann et al. [@CR229]), activating the Src kinase to phosphorylate the Dynamin 2 GTPase (Martin et al. [@CR171]), targeting the immunity-related GTPase M (IRGM) to the Golgi to induce GBF1 phosphorylation (Hansen et al. [@CR97]), modulating vesicular trafficking (Yadav et al. [@CR323]; Johns et al. [@CR120]), to impeding the major histocompatibility complex (MHC) class I trafficking, antigen presentation, and/or cytokine secretion (Moffat et al. [@CR183]; Rohde et al. [@CR237]).

Conclusions and Perspectives {#Sec23}
============================

The Golgi is the central hub in the secretory pathway, where proteins and lipids are processed, sorted, and dispatched to distinct destinations. As a well-organized polarized membrane structure, Golgi function is tightly related to its structural integrity. Thus, the first key question in Golgi biology concerns how the stacked Golgi structure forms. During the past decades, proteins with a variety of functions have been identified in the maintenance of Golgi structure and regulation of Golgi function, including but not limited to GRASPs, golgins, kinases, phosphatases, ubiquitin E3 ligases, and deubiquitinases, as summarized above. More detailed investigations need to be done to investigate how Golgi structural proteins and their interacting molecules cooperate together to form the stacked Golgi structure.

Golgi structural and functional defects have been increasingly reported in stress and disease conditions. In addition to its central role in protein sorting and trafficking, the Golgi has been more recently recognized as a hub of signaling pathways, which facilitates Golgi reaction upon stresses and diseases. Thus, the second key question in Golgi biology concerns how the Golgi structure becomes defective in stress and disease conditions. In this regard, much effort and some progress have been made, such as Golgi fragmentation in AD by Cdk5-mediated GRASP65 phosphorylation as discussed above. However, many questions remain. For example, is there an unfolded protein response (UPR)-like mechanism at the Golgi to cope with different stresses? Is there a common stress sensor on the Golgi? How do the signaling pathways on the Golgi sense and transduce stress signals? Apparently, a more systematic analysis of Golgi response to different stressors is necessary. Gene expression profile and posttranslational modification analysis of Golgi structural proteins, Golgi enzymes, and signaling molecules will fast forward the field and shed light on new directions. Considering lipid organization and modification are important for Golgi function and certain lipids can work as signaling molecules, more attention may be put on lipids at the Golgi, in addition to proteins.

The third key question in Golgi biology concerns how Golgi structure alteration affects its function in trafficking, glycosylation, and sorting. The consequence of Golgi fragmentation in different diseases is likely different, but it has been reported that Golgi cisternal unstacking by depleting GRASP proteins enhances protein trafficking. This, however, impairs accurate glycosylation and causes missorting of lysosomal enzymes to the extracellular space (Xiang et al. [@CR321]; Zhang and Wang [@CR334]; Bekier et al. [@CR22]; Wang et al. [@CR306]). Consistently, Golgi fragmentation in AD enhances APP trafficking and Aβ production, while rescue of the Golgi causes APP accumulation in the Golgi and reduces Aβ secretion (Joshi et al. [@CR122]). Most recently, we have obtained evidence that Golgi structure disassembly by GRASP depletion reduces cell attachment and migration while accelerating cell growth and cell cycle progression (Ahat et al. [@CR1]). It will be interesting to investigate how Golgi fragmentation enhances cancer cell proliferation and metastasis in the future. Future efforts may also aim at developing small chemicals or molecular tools to rescue the Golgi structure in diseases, which may delay the disease development.
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